• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ABLYF:US

10.2200 USD 0.1600 1.59%

As of 20:10:00 ET on 10/20/2014.

Snapshot for Ablynx NV (ABLYF)

Open: 10.2200 Day's Range: 10.2200 - 10.2200 Volume: 500
Previous Close: 10.0600 52wk Range: 9.2710 - 14.0000 1-Yr Rtn: -2.11%

Stock Chart for ABLYF

No chart data available.
  • ABLYF:US 10.2200
  • 1D
  • 1M
  • 1Y
10.0600
Interactive ABLYF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABLYF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.2770
Est. PEG Ratio -
Market Cap (M USD) 551.90
Shares Outstanding (M) 54.00
30 Day Average Volume 788
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABLYF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ABLYF

Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.

Edwin MosesChief Executive OfficerWim OttevaereChief Financial Officer
Josefin-Beate Holz "Josi"Chief Medical OfficerMarieke VermeerschAssociate Dir:Investor Relations
More Company Profile & Key Executives for ABLYF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil